Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajeka Lazarus

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2011
A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adultsRajeka Lazarus, Elizabeth Clutterbuck, Ly-Mee Yu, et al.
Trials|January 11, 2024
Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccines co-administered with seasonal influenza vaccines (ComFluCOV)Sarah Baos, Rachel Todd, Russell Thirard, et al.
The Journal of Infectious Diseases|March 30, 2012
Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cellsElizabeth A Clutterbuck, Rajeka Lazarus, Ly-Mee Yu, et al.
Plos One|November 5, 2016
Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly AdultsRajeka Lazarus, Sarah Kelly, Matthew D Snape, et al.
Vaccine|April 5, 2024
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trialHolly E Baum, Russell Thirard, Alice Halliday, et al.
Vaccine|September 19, 2009
Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adultsIsabel Leroux-Roels, Marie Van der Wielen, Froukje Kafeja, et al.
BMJ Open|January 8, 2021
Estimating the COVID-19 epidemic trajectory and hospital capacity requirements in South West England: a mathematical modelling frameworkRoss D Booton, Louis MacGregor, Lucy Vass, et al.
The Journal of Infection|July 5, 2023
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trialChristian Taucher, Rajeka Lazarus, Hanna Dellago, et al.
Clinical and Translational Science|October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trialSusanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.
Medicine|January 9, 2015
A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccineMainga Hamaluba, Rama Kandasamy, Susan Ndimah, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2011
A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adultsRajeka Lazarus, Elizabeth Clutterbuck, Ly-Mee Yu, et al.
Trials|January 11, 2024
Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccines co-administered with seasonal influenza vaccines (ComFluCOV)Sarah Baos, Rachel Todd, Russell Thirard, et al.
The Journal of Infectious Diseases|March 30, 2012
Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cellsElizabeth A Clutterbuck, Rajeka Lazarus, Ly-Mee Yu, et al.
Plos One|November 5, 2016
Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly AdultsRajeka Lazarus, Sarah Kelly, Matthew D Snape, et al.
Vaccine|April 5, 2024
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trialHolly E Baum, Russell Thirard, Alice Halliday, et al.
Vaccine|September 19, 2009
Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adultsIsabel Leroux-Roels, Marie Van der Wielen, Froukje Kafeja, et al.
BMJ Open|January 8, 2021
Estimating the COVID-19 epidemic trajectory and hospital capacity requirements in South West England: a mathematical modelling frameworkRoss D Booton, Louis MacGregor, Lucy Vass, et al.
The Journal of Infection|July 5, 2023
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trialChristian Taucher, Rajeka Lazarus, Hanna Dellago, et al.
Clinical and Translational Science|October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trialSusanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.
Medicine|January 9, 2015
A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccineMainga Hamaluba, Rama Kandasamy, Susan Ndimah, et al.
Pageof 5